Related Experiment Video
Updated: Jun 13, 2026
07:51
Refined Murine Model of Idiopathic Pulmonary Fibrosis
Published on: June 17, 2025
Altered fibroblast proteoglycan production in COPD.
Oskar Hallgren1, Kristian Nihlberg, Magnus Dahlbäck
1Department of Experimental Medical Science, BMC D12 Lund, Lund University, Sweden. oskar.hallgren@med.lu.se
Respiratory Research
|May 13, 2010
Summary
Fibroblast proteoglycan production is altered in COPD, impacting airway remodeling. Distal COPD fibroblasts overproduce versican, while central fibroblasts show reduced perlecan, affecting lung structure and function.
Area of Science:
- Pulmonary Medicine
- Cell Biology
- Biochemistry
Background:
- Chronic Obstructive Pulmonary Disease (COPD) involves extracellular matrix (ECM) reorganization.
- Proteoglycans are key regulators of ECM integrity and are implicated in COPD pathogenesis.
- Fibroblasts are primary producers of ECM components, with distinct central airway and alveolar populations proposed.
Purpose of the Study:
- To investigate if altered proteoglycan deposition (versican, perlecan) in COPD lungs stems from dysregulated fibroblast production.
- To compare proteoglycan production and response to TGF-beta1 in central and distal fibroblasts from COPD patients and controls.
Main Methods:
- Isolation of central airway and distal lung fibroblasts from COPD patients (GOLD stage IV) and controls.
- In vitro assessment of fibroblast proliferation, proteoglycan production, and response to TGF-beta1.
Main Results:
- Distinct fibroblast populations were identified in central airways and lung parenchyma.
- COPD distal fibroblasts showed significantly higher versican production (p < 0.01).
- COPD central fibroblasts exhibited significantly lower perlecan production (p < 0.01) and reduced TGF-beta1 responsiveness.
Conclusions:
- Fibroblast alterations in proteoglycan production contribute to COPD development.
- Enhanced versican in distal COPD fibroblasts may impair elastic recoil.
- Reduced perlecan in central COPD fibroblasts suggests compromised bronchial basement membrane integrity in severe COPD.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...